Literature DB >> 17547902

Recurrence risk for preterm delivery.

Julie McManemy1, Erinn Cooke, Erol Amon, Terry Leet.   

Abstract

OBJECTIVE: To estimate recurrence risk of preterm delivery in third births. STUDY
DESIGN: We conducted a population-based cohort study of Missouri mothers who delivered 3 consecutive singleton live births during 1989-1997. The recurrence risk was computed for 4 cohorts based on prior preterm delivery status and adjusted using Mantel-Haenszel stratified analysis.
RESULTS: The study population included 19,025 third births. The recurrence risk ranged from 42% (for women with 2 prior preterm deliveries), through 21% (term/preterm) and 13% (preterm/term), to 5% (term/term). The recurrence risk was highest (57%) for women with 2 prior very preterm deliveries (21-31 weeks) and lowest (33%) for those with 2 prior moderate preterm deliveries (32-36 weeks). The recurrence risk was less pronounced for women with 1 prior very or moderate preterm delivery.
CONCLUSION: These data show a strong association between prior preterm delivery and recurrence risk, which is affected by the frequency, order, and severity of prior preterm births.

Entities:  

Mesh:

Year:  2007        PMID: 17547902     DOI: 10.1016/j.ajog.2007.01.039

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  36 in total

1.  A case-control study of preterm delivery risk factors according to clinical subtypes and severity.

Authors:  Marisa Ip; Elmera Peyman; Vitool Lohsoonthorn; Michelle A Williams
Journal:  J Obstet Gynaecol Res       Date:  2010-02       Impact factor: 1.730

2.  Differences in risk factors for recurrent versus incident preterm delivery.

Authors:  Katherine L Grantz; Stefanie N Hinkle; Pauline Mendola; Lindsey A Sjaarda; Kira Leishear; Paul S Albert
Journal:  Am J Epidemiol       Date:  2015-06-01       Impact factor: 4.897

3.  Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.

Authors:  Tracy A Manuck; Gregory J Stoddard; Rebecca C Fry; M Sean Esplin; Michael W Varner
Journal:  Am J Obstet Gynecol       Date:  2016-07-11       Impact factor: 8.661

4.  Efficient linking of birth certificate and newborn screening databases for laboratory investigation of congenital cytomegalovirus infection and preterm birth: Florida, 2008.

Authors:  John M DePasquale; Karen Freeman; Minal M Amin; Sohyun Park; Samantha Rivers; Richard Hopkins; Michael J Cannon; Bonifacio Dy; Sheila C Dollard
Journal:  Matern Child Health J       Date:  2012-02

5.  Gestational age at previous preterm birth does not affect cerclage efficacy.

Authors:  Deborah A Wing; Jeff Szychowski; John Owen; Gary Hankins; Jay D Iams; Jeanne S Sheffield; Annette Perez-Delboy; Vincenzo Berghella; Edwin R Guzman
Journal:  Am J Obstet Gynecol       Date:  2010-06-26       Impact factor: 8.661

6.  Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate.

Authors:  Tracy A Manuck; Yinglei Lai; Paul J Meis; Mitchell P Dombrowski; Baha Sibai; Catherine Y Spong; Dwight J Rouse; Celeste P Durnwald; Steve N Caritis; Ronald J Wapner; Brian M Mercer; Susan M Ramin
Journal:  Am J Obstet Gynecol       Date:  2011-04-08       Impact factor: 8.661

7.  Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.

Authors:  Tracy A Manuck; M Sean Esplin; Joseph Biggio; Radek Bukowski; Samuel Parry; Heping Zhang; Hao Huang; Michael W Varner; William Andrews; George Saade; Yoel Sadovsky; Uma M Reddy; John Ilekis
Journal:  Am J Obstet Gynecol       Date:  2015-12-12       Impact factor: 8.661

8.  Timing of mid-trimester cervical length shortening in high-risk women.

Authors:  J M Szychowski; J Owen; G Hankins; J Iams; J Sheffield; A Perez-Delboy; V Berghella; D A Wing; E R Guzman
Journal:  Ultrasound Obstet Gynecol       Date:  2009-01       Impact factor: 7.299

9.  Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate.

Authors:  Jeff M Szychowski; Vincenzo Berghella; John Owen; Gary Hankins; Jay D Iams; Jeanne S Sheffield; Annette Perez-Delboy; Deborah A Wing; Edwin R Guzman
Journal:  J Matern Fetal Neonatal Med       Date:  2012-08-24

10.  Early pregnancy peripheral blood gene expression and risk of preterm delivery: a nested case control study.

Authors:  Daniel A Enquobahrie; Michelle A Williams; Chunfang Qiu; Seid Y Muhie; Kimberly Slentz-Kesler; Zhaoping Ge; Tanya Sorenson
Journal:  BMC Pregnancy Childbirth       Date:  2009-12-10       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.